According to the legal procedures, CSRC has approved the registration of the initial public offering of Jiangsu HOB Biotech (HOB) Co., Ltd. on the science and technology innovation board. The enterprise and its Underwriters will negotiate with the Shanghai Stock Exchange to determine the issuance schedule and publish the offering documents in succession.

HOB Biotech Group (HOB) is an innovative in vitro diagnostic company founded by overseas returnees with education and decades of industrial experience in the United States. The company specialized in providing diagnostic tools to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care. It is highly committed to providing innovative and effective, "affordable and reliable" diagnostic products for patients worldwide.

Since established in 2009, with dedicated R&D investment, HOB has gradually become in China the market leader in allergy diagnostics and a rising star in autoimmune diagnostics. It has established a world-class global R&D center in Suzhou, China and California, US, with a well experienced IVD product development team. HOB established a large-scale, ISO 13485 certified manufacturing facility in Suzhou, China, providing high quality products ranging from line immuno assay (BioLINE), enzyme-linked immunosorbent assay (BioLISA) to more advanced chemiluminescent paramagnetic microparticle immuno assay (BioCLIA).

The company strive to meet customer needs and continuously improve our service capabilities, and has built a customer service team covering 34 provinces and municipalities across China to provide professional technical service in a timely manner.

HOB’s mission is to develop and offer customers “affordable and reliable” products in allergy and autoimmune in vitro diagnostics, with the-state-of-art technologies, top-notch quality, and competitive pricing. As a leading manufacturer with strong R&D capability, HOB is expanding its global influence by forming strategic alliances with companies worldwide to provide high-quality and cost-effective products.